Human papillomavirus vaccination in adolescence

Area of Science:

• Oncology
• Immunology
• Public Health

Background:

• Cervical cancer is a significant global health issue, particularly in developing nations, primarily caused by persistent high-risk human papillomavirus (HPV) infections.
• While cervical screening programs have reduced incidence, HPV vaccination offers a proactive preventive strategy.
• High-risk HPV types 16 and 18 are responsible for approximately 70% of cervical cancers.

Purpose of the Study:

• To explore the health benefits and program delivery of HPV vaccination.
• To examine the impact of public attitudes, cost-effectiveness, and the role of school nurses in HPV vaccination programs.
• To assess the optimal strategy for HPV vaccination coverage, focusing on girls and potentially young men in specific contexts.

Main Methods:

• Review of existing evidence on HPV vaccine efficacy and impact.
• Analysis of vaccination program uptake rates and challenges.
• Exploration of cost-effectiveness and logistical considerations for vaccine delivery, including school-based programs.

Main Results:

• HPV vaccination targeting high-risk types 16 and 18 shows promise in reducing cervical cancer rates.
• Vaccination is most effective prior to sexual debut; uptake remains a challenge, necessitating parental education.
• School-based programs demonstrate effective uptake, though they impact school nurse service delivery.

Conclusions:

• HPV vaccination programs should focus on achieving and maintaining high coverage in girls.
• Targeting young men may offer benefits in areas with low female vaccination uptake.
• Continued efforts are needed to address uptake challenges and optimize delivery through school-based initiatives.